TNF and infection: The current treatments for patients with RA (DMARDs, NSAIDs, and anti-TNF biologics) intend to disrupt the inflammatory response and slow disease progression; however, their chronic consumption may lead to unwanted side effects (immunosuppression and infections) and prevent optimal resolution and tissue repair, which is imperative in RA.